Possible role of matriptase in the diagnosis of ovarian cancer


    loading  Checking for direct PDF access through Ovid

Abstract

There are increasing data that suggest a role for the serine protease matriptase and its inhibitor, hepatocyte growth factor activator inhibitor-1, in the pathogenesis and progression of ovarian cancer. This review will discuss the matriptase/inhibitor system in the context of ovarian cancer and examine the possibility that this system might be a useful therapeutic and/or diagnostic target in this disease.

    loading  Loading Related Articles